Results 211 to 220 of about 512,272 (346)

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture

, 2021
Khushboo Bafna, Kris M. White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas Acton, Elena Moreno, Thomas Kehrer, Lisa Miorin, Catherine A. Royer, Adolfo Garcı́a-Sastre, Robert M. Krug, G.T. Montelione   +12 more
openalex   +1 more source

Effects of High‐ and Low‐Fat Meals on the Bioavailability and Pharmacokinetics of Votoplam, a HTT Gene Splicing Modifier

Clinical Pharmacology in Drug Development, EarlyView.
Abstract Votoplam is a novel, orally bioavailable, small molecule HTT gene splicing modifier that is being developed for the treatment of Huntington's disease. This was a single dose, open‐label, two‐period, crossover food effect study that evaluated the effect of high‐ and low‐fat meals on 20 mg votoplam in healthy participants. There was a washout of
Lucy Lee, Amy‐Lee Richards, Nageswara Reddy, Brian Beers, Lee Golden, Ronald Kong   +5 more
wiley   +1 more source

MASLD and viral hepatitis overlap: An emerging dual burden in chronic liver disease. [PDF]

Hepatol Forum
Ejaz M, Kumar K, Sohail D, Sarfaraz I, Azam H, Yaseen F.   +5 more
europepmc   +1 more source

Nanoparticles in microdroplets: Recent advances in microfluidic generators for producing functional microbeads

Droplet, EarlyView.
Functional hybrid microbeads with electrical, magnetic, and/or optical responsiveness have emerged as versatile platforms for biotechnology. This review highlights recent advances in microfluidic technologies for producing such microbeads, with a focus on incorporating functional nanoparticles in microdroplet systems.
  Bayinqiaoge, Chengchen Zhang, Shi‐Yang Tang   +2 more
wiley   +1 more source

[Viral hepatitis].

Przeglad epidemiologiczny, 1978
D, Naruszewicz-Lesiuk, W, Magdzik
openaire   +7 more sources

Elimination of chronic viral hepatitis C in correctional health. [PDF]

Singapore Med J
Kumar R, Wong YJ, Tan J.
europepmc   +1 more source

Hemochromatosis gene modifies course of hepatitis C viral infection [PDF]

, 2003
Antonello Pietrangelo
openalex   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

Developmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff, Sandra Schrenk, Kara Soroko, Chhiring Sherpa, Ashok Arasu, Damien Reynaud, Elisa Boscolo   +6 more
wiley   +1 more source

Evolving insights into viral hepatitis: Advances, evidence, and expert perspectives from the ESCMID Study Group for Viral Hepatitis (ESGVH) - Part 2: hepatitis B, C, and delta. [PDF]

Germs
Săndulescu O, Matičič M, Garcia F, Blomé MA, Mondelli MU, Irving W, Zidovec-Lepej S, Widell A, Şahin GÖ, ESCMID Study Group for Viral Hepatitis (ESGVH).   +9 more
europepmc   +1 more source

Distribution of Hepatitis B Genotypes and viral load pattern among HBsAg positive Hepatitis B patients of different ethnic group of Nepal

, 2020
S. Lekhak, Gaurav Pandey, Bikki Gautam, Shova Banstola   +3 more
openalex   +1 more source